M. Allgäuer

发表

Lymphocyte-driven regional immunopathology in pneumonitis caused by impaired central immune tolerance

D. Mollura, Ziyue Xu, L. Notarangelo, 2019, Science Translational Medicine.

A Key Role for E-cadherin in Intestinal Homeostasis and Paneth Cell Maturation

E. Wolf, Benjamin Hirschi, F. Kolligs, 2010, PloS one.

The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases

R. Semrau, M. Duma, G. Hildebrandt, 2018, BMC Cancer.

Stereotactic body radiotherapy for centrally located stage I NSCLC

A. Grosu, F. Sterzing, M. Guckenberger, 2014, Strahlentherapie und Onkologie.

Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma

S. Fröhling, M. Kriegsmann, P. Schirmacher, 2021, Cancer Immunology, Immunotherapy.

RNA-Based Detection of Gene Fusions in Formalin-Fixed and Paraffin-Embedded Solid Cancer Samples

P. Schirmacher, A. Stenzinger, D. Kazdal, 2019, Cancers.

Spatial and temporal heterogeneity of panel-based tumor mutational burden (TMB) in pulmonary adenocarcinoma: separating biology from technical artifacts.

S. Fröhling, M. Kriegsmann, A. Warth, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

OC-0445: Patterns of care and outcome analysis of SBRT for liver metastases - a DEGRO database initiative

R. Semrau, M. Duma, G. Hildebrandt, 2016 .

KRAS/GNAS‐testing by highly sensitive deep targeted next generation sequencing improves the endoscopic ultrasound‐guided workup of suspected mucinous neoplasms of the pancreas

P. Schirmacher, A. Stenzinger, D. Kazdal, 2021, Genes, chromosomes & cancer.

Quantifying potential confounders of panel-based tumor mutational burden (TMB) measurement.

S. Fröhling, W. Weichert, P. Schirmacher, 2020, Lung cancer.

Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial.

T. Friede, R. Grützmann, C. Rödel, 2021, JAMA oncology.

Correlating dose variables with local tumor control in stereotactic body radiotherapy for early stage non-small cell lung cancer: A modelling study on 1500 individual treatments.

H. Eich, R. Sweeney, J. Sonke, 2020, International journal of radiation oncology, biology, physics.

U. Merle, D. Jaeger, M. Allgäuer, 2020, World journal of gastrointestinal oncology.

Conventional and semi-automatic histopathological analysis of tumor cell content for multigene sequencing of lung adenocarcinoma

M. Kriegsmann, J. Kriegsmann, R. Longuespée, 2021, Translational lung cancer research.

Loss of endogenous RNF43 function enhances proliferation and tumour growth of intestinal and gastric cells.

M. Vieth, M. Anton, K. Steiger, 2018, Carcinogenesis.

Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial

R. Pötter, W. Uter, J. Dunst, 2017, The Lancet. Oncology.

Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12.

T. Friede, R. Grützmann, J. Weitz, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity

S. Fröhling, E. Schröck, W. Weichert, 2022, Nature Communications.

Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers.

C. von Kalle, S. Fröhling, E. Schröck, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial.

W. Uter, J. Dunst, G. Hildebrandt, 2018, The Lancet. Oncology.

Bayesian Cure Rate Modeling of Local Tumor Control: Evaluation in Stereotactic Body Radiation Therapy for Pulmonary Metastases.

M. Duma, F. Sterzing, T. Wendt, 2016, International Journal of Radiation Oncology, Biology, Physics.

Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing

S. Fröhling, D. Kazdal, J. Budczies, 2022, British Journal of Cancer.

Estimation of the a / b ratio of non-small cell lung cancer treated with stereotactic body radiotherapy

H. Eich, R. Sweeney, J. Sonke, 2019 .

Estimation of the α/β ratio of non-small cell lung cancer treated with stereotactic body radiotherapy.

H. Eich, R. Sweeney, J. Sonke, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

COGNITION: a prospective precision oncology trial for patients with early breast cancer at high risk following neoadjuvant chemotherapy

A. Schneeweiss, M. Golatta, J. Heil, 2022, ESMO open.

Combined targeted DNA and RNA sequencing of advanced NSCLC in routine molecular diagnostics: Analysis of the first 3,000 Heidelberg cases

Olaf Neumann, Michael Thomas, Ivo Buchhalter, 2019, International journal of cancer.

Radiotherapy in the treatment of postoperative chylothorax

M. Allgäuer, R. Schemm, M. Ried, 2013, Journal of Cardiothoracic Surgery.

Stereotactic body radiotherapy for oligo-metastatic liver disease - Influence of pre-treatment chemotherapy and histology on local tumor control.

R. Semrau, M. Duma, G. Hildebrandt, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Homologous recombination deficiency is inversely correlated with microsatellite instability and identifies immunologically cold tumors in most cancer types

D. Kazdal, J. Budczies, T. Seufferlein, 2022, The journal of pathology. Clinical research.

Assigning evidence to actionability: An introduction to variant interpretation in precision cancer medicine

S. Fröhling, P. Schirmacher, A. Stenzinger, 2021, Genes, chromosomes & cancer.

The E3 ligase RNF43 inhibits Wnt signaling downstream of mutated β-catenin by sequestering TCF4 to the nuclear membrane

Michael Neumaier, Ignacio Varela, Roland Rad, 2015, Science Signaling.

A gene expression signature associated with B cells predicts benefit from immune checkpoint blockade in lung adenocarcinoma

S. Fröhling, M. Kriegsmann, P. Schirmacher, 2021, Oncoimmunology.

Variant classification in precision oncology

Melanie Boerries, Olaf Neumann, Michael Thomas, 2019, International journal of cancer.

Optimizing panel-based tumor mutational burden (TMB) measurement.

S. Fröhling, P. Schirmacher, A. Stenzinger, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Measurement of tumor mutational burden (TMB) in routine molecular diagnostics: in silico and real‐life analysis of three larger gene panels

Olaf Neumann, Michael Thomas, Ivo Buchhalter, 2019, International journal of cancer.

Size matters: Dissecting key parameters for panel‐based tumor mutational burden analysis

Olaf Neumann, Michael Thomas, Ivo Buchhalter, 2018, International journal of cancer.

Implementing tumor mutational burden (TMB) analysis in routine diagnostics-a primer for molecular pathologists and clinicians.

Olaf Neumann, Michael Thomas, Jan Budczies, 2018, Translational lung cancer research.

Intraductal tubulopapillary neoplasms of the bile ducts: clinicopathologic, immunohistochemical, and molecular analysis of 20 cases

R. Hruban, Seung‐Mo Hong, O. Basturk, 2015, Modern Pathology.

Targeting rare and non-canonical driver variants in NSCLC - An uncharted clinical field.

S. Fröhling, M. Kriegsmann, P. Schirmacher, 2021, Lung cancer.

Detection of TP53 Mutations in Tissue or Liquid Rebiopsies at Progression Identifies ALK+ Lung Cancer Patients with Poor Survival

P. Schirmacher, A. Stenzinger, J. Budczies, 2019, Cancers.

Several genotypes, one phenotype: PIK3CA/AKT1 mutation-negative hidradenoma papilliferum show genetic lesions in other components of the signalling network.

W. Weichert, P. Schirmacher, A. Stenzinger, 2019, Pathology.

Artificial Intelligence and Pathology: from Principles to Practice and Future Applications in Histomorphology and Molecular Profiling.

K. Müller, F. Tacke, M. Alber, 2021, Seminars in cancer biology.

Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary

W. Weichert, P. Schirmacher, A. Stenzinger, 2020, International journal of cancer.

Comparative genetic profiling aids diagnosis and clinical decision making in challenging cases of CUP syndrome

P. Schirmacher, A. Stenzinger, A. Krämer, 2019, International journal of cancer.

Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer.

Matthias Guckenberger, Ursula Nestle, Michael Allgäuer, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

MCL1 as putative target in pancreatoblastoma

S. Fröhling, A. Scarpa, C. Luchini, 2022, Virchows Archiv.

Metastatic adult pancreatoblastoma: Multimodal treatment and molecular characterization of a very rare disease.

S. Fröhling, D. Jäger, E. Schröck, 2020, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

R. Semrau, M. Duma, G. Hildebrandt, 2018, BMC Cancer.

Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy.

Oliver Blanck, Robert Krempien, Matthias Guckenberger, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Intraductal tubulopapillary neoplasms of the bile ducts: clinicopathologic, immunohistochemical, and molecular analysis of 20 cases

R. Hruban, Seung‐Mo Hong, O. Basturk, 2016, Modern Pathology.

Optimizing panel-based tumor mutational burden (TMB) measurement.

S. Fröhling, P. Schirmacher, A. Stenzinger, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Indurated erythema of abdominal skin: An unusual presentation of metastatic endometrial carcinoma—Case report with literature review

K. Drexler, S. Karrer, J. Braess, 2022, Skin health and disease.

A Cell Line–based Immunohistochemical p53 Expression Pattern Control Panel

D. Xing, R. Howard, M. Allgäuer, 2019, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial

Richard Pötter, Wolfgang Uter, Tibor Major, 2016, The Lancet.

Mitochondrial function controls intestinal epithelial stemness and proliferation

M. Heikenwalder, M. Prinz, D. Haller, 2016, Nature Communications.

First proficiency testing for NGS‐based and combined NGS‐ and FISH‐based detection of FGFR2 fusions in intrahepatic cholangiocarcinoma

W. Weichert, D. Kazdal, M. Kirchner, 2023, The journal of pathology. Clinical research.

Salvage therapy in patients with glioblastoma

U. Bogdahn, G. Schuierer, K. Fabel, 2003, Cancer.

Loss of RNF43 Function Contributes to Gastric Carcinogenesis by Impairing DNA Damage Response

W. Weichert, E. Kremmer, M. Vieth, 2020, Cellular and molecular gastroenterology and hepatology.

Follicular lymphoma, immunocytoma, and mantle cell lymphoma: Randomized evaluation of curative radiotherapy in limited stage nodal disease

N. Willich, C. Rübe, M. Engelhard, 2006 .

Afatinib with Concurrent Radiotherapy in a Patient with Metastatic Non-Small Cell Lung Cancer

S. Al-Batran, E. Jäger, A. Atmaca, 2014, Oncology Research and Treatment.

Support vector machine-based prediction of local tumor control after stereotactic body radiation therapy for early-stage non-small cell lung cancer.

Matthias Guckenberger, Ursula Nestle, Michael Allgäuer, 2014, International journal of radiation oncology, biology, physics.

Immuno‐oncology gene expression profiling of formalin‐fixed and paraffin‐embedded clear cell renal cell carcinoma: Performance comparison of the NanoString nCounter technology with targeted RNA sequencing

P. Schirmacher, A. Stenzinger, D. Kazdal, 2020, Genes, chromosomes & cancer.

The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinoma

S. Fröhling, M. Kriegsmann, P. Schirmacher, 2021, ESMO open.

Next generation sequencing of the cellular and liquid fraction of pancreatic cyst fluid supports discrimination of IPMN from pseudocysts and reveals cases with multiple mutated driver clones: First findings from the prospective ZYSTEUS biomarker study

P. Schirmacher, A. Stenzinger, R. Penzel, 2018, Genes, chromosomes & cancer.

[Ultrasound volumetry of cervical lymph nodes during radiotherapy as a method of therapy monitoring].

H. Feldmann, M. Molls, M. Allgäuer, 2008, Ultraschall in der Medizin.

Effect of timing, technique and molecular features on brain control with local therapies in oncogene-driven lung cancer

J. Debus, A. Stenzinger, D. Kazdal, 2021, ESMO open.

GEC-ESTRO multicenter phase 3-trial: Accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: Early toxicity and patient compliance.

Richard Pötter, Wolfgang Uter, Tibor Major, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

De Novo Versus Secondary Metastatic EGFR-Mutated Non-Small-Cell Lung Cancer

M. Kriegsmann, A. Stenzinger, D. Kazdal, 2021, Frontiers in Oncology.

Safety and Efficacy of Stereotactic Body Radiotherapy for Stage I Non–Small-Cell Lung Cancer in Routine Clinical Practice: A Patterns-of-Care and Outcome Analysis

F. Sterzing, M. Guckenberger, K. Dieckmann, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Glycodelin acts as an immunomodulator in NSCLC and is a predictor of poor prognosis for patients receiving immunotherapy

D. Kazdal, T. Goldmann, U. Klingmüller, 2023, bioRxiv.

Analysis of rare fusions in NSCLC: genomic architecture and clinical implications

D. Kazdal, J. Budczies, F. Herth, 2023, Lung Cancer.

Morphomolecular analysis of the immune tumor microenvironment in human head and neck cancer

W. Weichert, P. Schirmacher, A. Stenzinger, 2019, Cancer Immunology, Immunotherapy.

Accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy compared with whole-breast irradiation with boost for early breast cancer: 10-year results of a GEC-ESTRO randomised, phase 3, non-inferiority trial.

W. Uter, G. Hildebrandt, R. Fietkau, 2023, The Lancet. Oncology.

Spatial profiling of the microenvironment reveals low intratumoral heterogeneity and STK11-associated immune evasion in therapy-naïve lung adenocarcinomas.

D. Kazdal, J. Budczies, F. Herth, 2023, Lung cancer.

Afatinib with Concurrent Radiotherapy in a Patient with Metastatic Non-Small Cell Lung Cancer

S. Al-Batran, E. Jäger, A. Atmaca, 2014, Oncology Research and Treatment.

Prognostic Impact of the Immune-Cell Infiltrate in N1-Positive Non-Small-Cell Lung Cancer.

M. Kriegsmann, R. Savai, T. Muley, 2023, Clinical lung cancer.

Safety and Efficacy of Stereotactic Body Radiotherapy for Stage I Non–Small-Cell Lung Cancer in Routine Clinical Practice: A Patterns-of-Care and Outcome Analysis

F. Sterzing, M. Guckenberger, K. Dieckmann, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients

J. Budczies, M. Boerries, S. Lassmann, 2023, NPJ precision oncology.